DeMethyl Isradipine, with the CAS number 88977-30-4, is a chemical compound that belongs to the class of dihydropyridine calcium channel blockers. It is primarily characterized by its role in the treatment of hypertension and angina pectoris. The compound functions by selectively inhibiting calcium influx through L-type calcium channels in vascular smooth muscle and cardiac tissue, leading to vasodilation and reduced cardiac workload. DeMethyl Isradipine is a derivative of Isradipine, with a methyl group removed, which can influence its pharmacological properties and potency. The substance is typically administered in oral form and is known for its relatively long half-life, allowing for once-daily dosing in clinical settings. Its safety profile includes common side effects such as dizziness, flushing, and peripheral edema, which are typical of calcium channel blockers. As with any medication, it is essential to consider potential drug interactions and contraindications when prescribing DeMethyl Isradipine.

DeMethyl Isradipine

88977-30-4: DeMethyl Isradipine, with the CAS number 88977-30-4, is a chemical compound that belongs to the class of dihydropyridine calcium channel blockers. It is primarily characterized by its role in the treatment of hypertension and angina pectoris. The compound functions by selectively inhibiting calcium influx through L-type calcium channels in vascular smooth muscle and cardiac tissue, leading to vasodilation and reduced cardiac workload. DeMethyl Isradipine is a derivative of Isradipine, with a methyl group removed, which can influence its pharmacological properties and potency. The substance is typically administered in oral form and is known for its relatively long half-life, allowing for once-daily dosing in clinical settings. Its safety profile includes common side effects such as dizziness, flushing, and peripheral edema, which are typical of calcium channel blockers. As with any medication, it is essential to consider potential drug interactions and contraindications when prescribing DeMethyl Isradipine.

CAS 88977-30-4

DeMethyl Isradipine

Demethyl Isradipine

Ref: 4Z-I-0813

Demethyl Isradipine

Ref: TR-D231185